Steve is CTO at the Markley Group, New England’s premium provider of Colocation, Connectivity and Cloud services supporting Academia, Life Science and Financial Service organizations.
After obtaining his PhD in Chemical Crystallography in 1992, he continued his research career at the University of Calgary. During this time he was exposed to his first “super computer”-the Fujitsu VPX240, and realized the impact HPCC could have on scientific discovery. This was followed by a move to Harvard University in 1998 working under the supervision of Professors Don Wiley and Steve Harrison in the area of macromolecular and computational crystallography.
Following a brief adventure into telecom startups, he came back into the scientific computing world as HPC lead at Vertex Pharmaceuticals.
In 2004 he joined the Novartis Institutes for Biomedical Research as the Global lead for Scientific Computing, specializing in the application of High Performance, Data Analytics and Cloud Computing to advance drug discovery. After 14 years in the role he moved to Markley as CTO where he remains today.